RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. National Kidney Foundation
N

National Kidney Foundation portfolio

National Kidney Foundation has 2 portfolio companies on record at Recent Funding, with 2 investments in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 2.
Rounds led: 1 of 2.
Capital in their rounds: $103M.
Latest deal: Estuary Biotherapeutics · Oct 16, 2026.
About this page

It led 1 of the 2 rounds it joined. Its most recent investment on record is Estuary Biotherapeutics's $103M Series A round in October 2026, alongside 4BIO Capital, UPMC Enterprises, Deep Track Capital and 4 others. By category, its portfolio leans toward Health and bio (2). It has co-invested with GV, RA Capital Management and Deep Track Capital.

What National Kidney Foundation invests in

How National Kidney Foundation invests

StageDealsCapital in rounds
Series A 1 50%$103M
Seed 1 50%undisclosed

National Kidney Foundation portfolio companies

CompanyRound with National Kidney FoundationTotal raisedLatest raise
EEstuary Biotherapeutics
Health and bio
Series A · $103M$103MOct 16, 2026
Series A
NNephrogen
Health and bio
Seed · leadundisclosedOct 6, 2026
Seed

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 2 rounds on Recent Funding that name National Kidney Foundation. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists National Kidney Foundation, which is a subset of its real portfolio. API: /api/v1/investors/national-kidney-foundation (get a free API key). More: the most active VC firms and new venture capital funds.